Aortic Smooth Muscle Cells Migration and the Role of Metalloproteinases and Hyaluronan

REFERENCES

• Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801–809
   PubMed Web of Science ®Google Scholar
• Halayko A.J., Solway J. Molecular mechanisms of phenotypic plasticity in smooth muscle cells. J. Appl. Physiol. 2001; 90: 358–368
   PubMed Web of Science ®Google Scholar
• Passi A., Negrini D., Albertini R., Miserocchi G., De Luca G. The sensitivity of versican from rabbit lung to gelatinase A (MMP-2) and B (MMP-9) and its involvement in the development of hydraulic lung edema. FEBS Lett. 1999; 456: 93–96
   PubMed Web of Science ®Google Scholar
• Toole B.P. Hyaluronan: from extracellular glue to pericellular cue. Nat. Rev. Cancer 2004; 4: 528–539
   PubMed Web of Science ®Google Scholar
• Vigetti D., Viola M., Karousou E., Rizzi M., Moretto P., Genasetti A., Clerici M., Hascall V.C., De Luca G., Passi A. Hyaluronan-CD44-ERK1/2 regulate human aortic smooth muscle cell motility during aging. J. Biol. Chem. 2008; 283: 4448–4458
   PubMed Web of Science ®Google Scholar
• Kuzuya M., Kanda S., Sasaki T., Tamaya-Mori N., Cheng X.W., Itoh T., Itohara S., Iguchi A. Deficiency of gelatinase A suppresses smooth muscle cell invasion and development of experimental intimal hyperplasia. Circulation 2003; 108: 1375–1381
   PubMed Web of Science ®Google Scholar
• Iozzo R.V. Matrix proteoglycans: from molecular design to cellular function. Annu. Rev. Biochem. 1998; 67: 609–652
   PubMed Web of Science ®Google Scholar
• Sternlicht M.D., Werb Z. How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol. 2001; 17: 463–516
   PubMed Web of Science ®Google Scholar
• Whatling C., McPheat W., Hurt-Camejo E. Matrix management: assigning different roles for MMP-2 and MMP-9 in vascular remodeling. Arterioscler. Thromb. Vasc. Biol. 2004; 24: 10–11
   PubMed Web of Science ®Google Scholar
• Galis Z.S., Muszynski M., Sukhova G.K., Simon-Morrissey E., Unemori E.N., Lark M.W., Amento E., Libby P. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ. Res. 1994; 75: 181–189
   PubMed Web of Science ®Google Scholar
• Li Z., Froehlich J., Galis Z.S., Lakatta E.G. Increased expression of matrix metalloproteinase-2 in the thickened intima of aged rats. Hypertension 1999; 33: 116–123
   PubMed Web of Science ®Google Scholar
• Johnson C., Galis Z.S. Matrix metalloproteinase-2 and -9 differentially regulate smooth muscle cell migration and cell-mediated collagen organization. Arterioscler. Thromb. Vasc. Biol. 2004; 24: 54–60
   PubMed Web of Science ®Google Scholar
• Katsuda S., Kaji T. Atherosclerosis and extracellular matrix. J. Atheroscler. Thromb. 2003; 10: 267–274
   PubMedGoogle Scholar
• Lijnen H.R. Metalloproteinases in development and progression of vascular disease. Pathophysiol. Haemost. Thromb. 2003; 33: 275–281
   PubMed Web of Science ®Google Scholar
• McNulty M., Spiers P., McGovern E., Feely J. Aging is associated with increased matrix metalloproteinase-2 activity in the human aorta. Am. J. Hypertens. 2005; 18: 504–509
   PubMed Web of Science ®Google Scholar
• Seiki M. Membrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasion. Cancer Lett. 2003; 194: 1–11
   PubMed Web of Science ®Google Scholar
• Vigetti D., Moretto P., Viola M., Genasetti A., Rizzi M., Karousou E., Pallotti F., De Luca G., Passi A. Matrix metalloproteinase 2 and tissue inhibitors of metalloproteinases regulate human aortic smooth muscle cell migration during in vitro aging. FASEB J. 2006; 20: 1118–1130
   PubMed Web of Science ®Google Scholar
• Lambert E., Dasse E., Haye B., Petitfrere E. TIMPs as multifacial proteins. Crit. Rev. Oncol. Hematol. 2004; 49: 187–198
   PubMed Web of Science ®Google Scholar
• Kadoglou N.P., Liapis C.D. Matrix metalloproteinases: contribution to pathogenesis, diagnosis, surveillance and treatment of abdominal aortic aneurysms. Curr. Med. Res. Opin. 2004; 20: 419–432
   PubMed Web of Science ®Google Scholar
• Cheng L., Mantile G., Pauly R., Nater C., Felici A., Monticone R., Bilato C., Gluzband Y.A., Crow M.T., Stetler-Stevenson W., Capogrossi M.C. Adenovirus-mediated gene transfer of the human tissue inhibitor of metalloproteinase-2 blocks vascular smooth muscle cell invasiveness in vitro and modulates neointimal development in vivo. Circulation 1998; 98: 2195–2201
   PubMed Web of Science ®Google Scholar
• McCaffrey T.A., Nicholson A.C., Szabo P.E., Weksler M.E., Weksler B.B. Aging and arteriosclerosis. The increased proliferation of arterial smooth muscle cells isolated from old rats is associated with increased platelet-derived growth factor-like activity. J. Exp. Med. 1988; 167: 163–174
   PubMed Web of Science ®Google Scholar
• Riessen R., Wight T.N., Pastore C., Henley C., Isner J.M. Distribution of hyaluronan during extracellular matrix remodeling in human restenotic arteries and balloon-injured rat carotid arteries. Circulation 1996; 93: 1141–1147
   PubMed Web of Science ®Google Scholar
• Cuff C.A., Kothapalli D., Azonobi I., Chun S., Zhang Y., Belkin R., Yeh C., Secreto A., Assoian R.K., Rader D.J., Pure E. The adhesion receptor CD44 promotes atherosclerosis by mediating inflammatory cell recruitment and vascular cell activation. J. Clin. Invest. 2001; 108: 1031–1040
   PubMed Web of Science ®Google Scholar
• Nedvetzki S., Gonen E., Assayag N., Reich R., Williams R.O., Thurmond R.L., Huang J., Neudecker B.A., Wang F., Turley E.A., Naor D. RHAMM, a receptor for hyaluronan-mediated motility, compensates for CD44 in inflamed CD44-knockout mice: a different interpretation of redundacy. Proc. Natl. Acad. Sci. USA, 101: 18081–18086
   PubMed Web of Science ®Google Scholar
• Isacke C.M., Yarwood H. The hyaluronan receptor, CD44. Int. J. Biochem. Cell Biol. 2002; 34: 718–721
   PubMed Web of Science ®Google Scholar
• Troen B.R. The biology of aging. Mt. Sinai J. Med. 2003; 70: 3–22
   PubMed Web of Science ®Google Scholar
• Chang E., Harley C.B. Telomere length and replicative aging in human vascular tissues. Proc. Natl. Acad. Sci. USA 1995; 92: 11190–11194
   PubMed Web of Science ®Google Scholar
• Martin G.M., Ogburn C.E., Wight T.N. Comparative rates of decline in the primary cloning efficiencies of smooth muscle cells from the aging thoracic aorta of two murine species of contrasting maximum life span potentials. Am. J. Pathol. 1983; 110: 236–245
   PubMed Web of Science ®Google Scholar
• Ruiz-Torres A., Lozano R., Melon J., Carraro R. Age-dependent decline of in vitro migration (basal and stimulated by IGF-1 or insulin) of human vascular smooth muscle cells. J. Gerontol. A Biol. Sci. Med. Sci. 2003; 58: B1074–B1077
   Google Scholar
• Li Z., Cheng H., Lederer W.J., Froehlich J., Lakatta E.G. Enhanced proliferation and migration and altered cytoskeletal proteins in early passage smooth muscle cells from young and old rat aortic explants. Exp. Mol. Pathol. 1997; 64: 1–11
   PubMed Web of Science ®Google Scholar
• Lundberg M.S., Crow M.T. Age-related changes in the signaling and function of vascular smooth muscle cells. Exp. Gerontol. 1999; 34: 549–557
   PubMed Web of Science ®Google Scholar